Research Article: De novo and recurrent post-transplant membranous nephropathy cases show similar rates of concurrent antibody-mediated rejection
Abstract:
Background: Membranous nephropathy (MN) can develop post-kidney transplant and is classified as a recurrent disease in patients with a history of MN in the native kidneys or as de novo disease in patients without such history. The mechanism of recurrent MN is thought to be like that of primary MN, but the mechanism of de novo MN is not well delineated. An association between de novo MN and antibody-mediated rejection (AMR) has been suggested.
No summary available.